Nuvation Bio (NUVB) Accumulated Expenses (2023 - 2025)
Historic Accumulated Expenses for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $32.6 million.
- Nuvation Bio's Accumulated Expenses rose 3859.87% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 3859.87%. This contributed to the annual value of $32.8 million for FY2024, which is 23527.01% up from last year.
- According to the latest figures from Q3 2025, Nuvation Bio's Accumulated Expenses is $32.6 million, which was up 3859.87% from $24.0 million recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Accumulated Expenses ranged from a high of $32.8 million in Q4 2024 and a low of $8.4 million during Q1 2023
- Moreover, its 3-year median value for Accumulated Expenses was $20.0 million (2024), whereas its average is $18.9 million.
- As far as peak fluctuations go, Nuvation Bio's Accumulated Expenses surged by 23527.01% in 2024, and later skyrocketed by 2014.62% in 2025.
- Nuvation Bio's Accumulated Expenses (Quarter) stood at $9.8 million in 2023, then surged by 235.27% to $32.8 million in 2024, then dropped by 0.77% to $32.6 million in 2025.
- Its Accumulated Expenses stands at $32.6 million for Q3 2025, versus $24.0 million for Q2 2025 and $23.9 million for Q1 2025.